Navigation Links
BioMarin Announces Third Quarter 2009 Financial Results
Date:10/28/2009

providers and patients to better manage PKU. These programs include a state-of-the-art handheld device to measure blood Phe levels in PKU patients. Human studies are planned for 2010. Regulatory approval and commercial availability of the handheld blood Phe monitor is expected in the first half of 2011.
  • BMN-185 - IgA protease for IgA nephropathy: BioMarin is completing early preclinical work and expects to move to the next phase of research in the first half of 2010. IgA proteases have been shown to cleave IgA complexes, the deposition of which causes IgA nephropathy, an orphan kidney disorder with few treatment alternatives.
  • Additional early development candidates: BioMarin is working on multiple early development opportunities and expects to announce the next IND candidate in the first half of 2010.
  • BMN-103 - a-glucosidase (GAA) for Pompe Disease: BMN-103 is a highly phosphorylated GAA enzyme, which the company believes could result in more efficient uptake in cells and potentially lead to improved glycogen reduction in key affected muscle groups not addressed with current therapy. BioMarin continues to explore partnering options for this program.
  • 6R-BH4 Cardiovascular: BioMarin has decided to put the PAH opportunity for 6R-BH4 on hold, pending discussions with potential partners. Although the early data suggest a potential for 6R-BH4 to be a safe and efficacious therapy for PAH, BioMarin decided that the additional investment in time and resources required to demonstrate this effect is better allocated to other early pipeline candidates.
  • Non-GAAP Financial Information and Reconciliation

    The above results for the quarter and nine months ended September 30, 2009 and 2008, full year results for 2008 and financial guidance for 2009 are presented both as determined in accordance with GAAP and on a non-GAAP basis. As used in this release, non-GAAP income is cal
    '/>"/>

    SOURCE BioMarin Pharmaceutical Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

    Related medicine technology :

    1. BioMarin to Present at the Oppenheimer Healthcare Conference
    2. BioMarin Acquires Huxley Pharmaceuticals, Inc.
    3. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
    4. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
    5. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
    6. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
    7. BioMarin Announces FDA Approval for Kuvan
    8. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
    9. Rigel Announces Presentations at Two Investor Conferences
    10. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
    11. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/21/2014)...  An International Trade Commission (ITC) ruling issued Friday ... device, Taiwanese device manufacturer APEX continues to infringe ResMed ... ) is the innovation leader and pioneer in designing ... "Our research and development teams are ... of comfort, performance and efficacy," said David Pendarvis ...
    (Date:7/21/2014)... Apex Medical Corporation (Apex, TWSE: 4106), a leading player ... announces that the United States International Trade Commission (USITC) ... newly designed XT series continuous positive airway pressure (CPAP) ... the patent claims asserted by ResMed, one of Apex,s ... an upgraded iCH water tank to the market in ...
    (Date:7/18/2014)... 2014 Hanger, Inc. (NYSE: HGR ) ... operations for the quarter ended June 30, 2014, on Tuesday, ... to discuss these results is scheduled to begin at 9:00 ... participate should call 1-877-662-6095. A replay will be available until ... ID # 44683027. About Hanger, Inc. – Built ...
    Breaking Medicine Technology:ITC Rules Redesigned APEX Humidifier Still Infringes ResMed Patents 2Apex Medical's Respiratory Therapy Product Receives Affirmation from USITC 2
    ... an international generic pharmaceuticals company, today announced that ... Food & Drug Administration to market Zolpidem Tartrate ... the product has commenced.   Actavis ... Extended-Release Tablets 6.25 mg strength in October 2010 with ...
    ... 6, 2011 Pharmacyclics, Inc. (Nasdaq: PCYC ... the Phase IB/II study of the Btk inhibitor, PCI-32765, ... (CLL/SLL) at the 2011 American Society of Clinical Oncology ... development program update for the Btk Inhibitor, PCI-32765.  The ...
    Cached Medicine Technology:Actavis Receives FDA Approval of Zolpidem Tartrate Extended-Release Tablets USP, 12.5 mg CIV in the U.S. 2Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 2Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 3Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 4Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 5Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 6Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 7Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 8Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 9
    (Date:7/21/2014)... 2014 iFitDress.com, a famous company of ... announced its exclusive collection of 2014 glitter evening ... for its brand new gowns. , iFitDress.com is one ... market. Its sales boomed in the recent years, not ... also because of the amicable services offered on its ...
    (Date:7/21/2014)... MA (PRWEB) July 21, 2014 What ... extramarital affair have in common? You can find them ... Heart! The novel's main character, Miranda, lives on Martha’s ... meets Clay, a wealthy New Yorker, and becomes entangled ... of the Heart challenges readers to think about what ...
    (Date:7/21/2014)... Executives from Advice Media, the ... healthcare practices, will participate in this week’s International ... showcasing their state-of-the-art capabilities and successes in implementing ... the United States as the importance for doctors ... Advice Media’s presence at IACA comes on the ...
    (Date:7/21/2014)... Press-NORC Center for Public Affairs Research has released the ... about what it means to be a quality health ... by the Robert Wood Johnson Foundation, sheds new light ... health care and doctors, as well as the information ... The survey produces new and actionable data during a ...
    (Date:7/21/2014)... 21, 2014 (HealthDay News) -- Good parenting and ... children from low-income families, a new study suggests. ... children, and can lead to a number of ... health problems in both childhood and adulthood involve ... diabetes, heart disease, allergies and some cancers," study ...
    Breaking Medicine News(10 mins):Health News:iFitDress.com: 2014 Glitter Evening Dresses For Worldwide Clients 2Health News:Thea Marsh Releases Debut Novel that Celebrates and Reaches out to Women Everywhere 2Health News:Advice Media to Attend the International Association of Comprehensive Aesthetics Conference (IACA) Targeting the Dental Profession 2Health News:National survey from AP-NORC examines perceptions of health care provider quality 2Health News:Life Skills, Parenting Classes May Cut Inflammation in Poor Kids 2
    ... unclear why it’s so, scientists at Johns Hopkins have linked ... tough//, protective casing that houses insects and worms to the ... ,A team of Hopkins sinus experts has found that the ... to 250 times more active in people with severe sinus ...
    ... say that there is nothing that matches gambling. Not even ... addict//. ,There has been an upsurge of gambling ... with gambling problems. According to some experts, this has led ... ,"It's related to other addictions, like alcoholism and tobacco addiction. ...
    ... may no longer be included in the specialist category, if ... ,A few radiologists who have had the opportunity ... them as part of the team. But the rest are ... physicians are unable to seek employment in breast clinics. And ...
    ... common man has seen a rapid increase in healthcare charges ... been affected not only by the rising cost of living// ... money-spinning business. ,The government in 2003 revised the ... had the benefit of ‘free’ hospital visits. In fact, they ...
    ... 10, sent a warning against dengue fever in the midst ... capital//. ,From this year’s January 1 to ... been reported, said the department. ,In order ... collaboration with the local officials of the affected areas, according ...
    ... and Drug Administration has charged the American Red Cross yet ... to the stipulation of safe blood collection techniques.// The Red ... the nation's requirement of blood, has been under the vigilance ... make the blood safe by enhancing the quality control system., ...
    Cached Medicine News:Health News:Immune Response Linked to “Ghost” Parasites and Severely Congested Sinus 2Health News:Immune Response Linked to “Ghost” Parasites and Severely Congested Sinus 3Health News:Immune Response Linked to “Ghost” Parasites and Severely Congested Sinus 4Health News:Compulsive Gambling – a psychiatric disorde 2Health News:Escalating Healthcare charges in UAE 2Health News:Escalating Healthcare charges in UAE 3Health News:‘Search and Destroy’ operation against dengue mosquitoes in Philippin 2
    Determination of the Thrombin Time by STA Analyzers. Freeze-dried human thrombin (1.5NIH units/mL) with calcium....
    Quantitative determination of Fibrinogen (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
    Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
    Determination of Prothrombin Time (PT)by STA Analyzers (ISI~1.8).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
    Medicine Products: